224 related articles for article (PubMed ID: 12429790)
1. Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes.
Leroy X; Zini L; Leteurtre E; Zerimech F; Porchet N; Aubert JP; Gosselin B; Copin MC
Mod Pathol; 2002 Nov; 15(11):1126-30. PubMed ID: 12429790
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of morphologic subdivision of papillary renal cell carcinoma and MUC1 expression].
Blel A; Kourda N; Baltagi Ben Jilani S; Zermani R
Prog Urol; 2008 Oct; 18(9):575-9. PubMed ID: 18986629
[TBL] [Abstract][Full Text] [Related]
3. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
[TBL] [Abstract][Full Text] [Related]
4. [Papillary renal cell carcinoma: clinico-pathologic studies of 33 cases].
Liu LN; Chen GY; Wang P; Zhang CH; Huang SF
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):102-5. PubMed ID: 15946550
[TBL] [Abstract][Full Text] [Related]
5. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of caveolin-1 in renal neoplasms.
Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
[TBL] [Abstract][Full Text] [Related]
7. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
[TBL] [Abstract][Full Text] [Related]
8. A molecular classification of papillary renal cell carcinoma.
Yang XJ; Tan MH; Kim HL; Ditlev JA; Betten MW; Png CE; Kort EJ; Futami K; Furge KA; Takahashi M; Kanayama HO; Tan PH; Teh BS; Luan C; Wang K; Pins M; Tretiakova M; Anema J; Kahnoski R; Nicol T; Stadler W; Vogelzang NG; Amato R; Seligson D; Figlin R; Belldegrun A; Rogers CG; Teh BT
Cancer Res; 2005 Jul; 65(13):5628-37. PubMed ID: 15994935
[TBL] [Abstract][Full Text] [Related]
9. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features.
Kunju LP; Wojno K; Wolf JS; Cheng L; Shah RB
Hum Pathol; 2008 Jan; 39(1):96-101. PubMed ID: 17949780
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.
Sika-Paotonu D; Bethwaite PB; McCredie MR; William Jordan T; Delahunt B
Am J Surg Pathol; 2006 Sep; 30(9):1091-6. PubMed ID: 16931953
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma.
Perret AG; Clemencon A; Li G; Tostain J; Peoc'h M
BJU Int; 2008 Jul; 102(2):183-7. PubMed ID: 18422770
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors.
Gunawan B; von Heydebreck A; Fritsch T; Huber W; Ringert RH; Jakse G; Füzesi L
Cancer Res; 2003 Oct; 63(19):6200-5. PubMed ID: 14559804
[TBL] [Abstract][Full Text] [Related]
13. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
15. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA
Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589
[TBL] [Abstract][Full Text] [Related]
16. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
[TBL] [Abstract][Full Text] [Related]
17. Pax-2 expression in adult renal tumors.
Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
[TBL] [Abstract][Full Text] [Related]
18. [Expression of VEGFR-2 and VEGFR-3 in papillary renal cell carcinoma and their relationship with prognosis].
Zhang YH; Diao L; Yang Q; Duo J; Liu YX; Liu SX; Yao X
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):752-6. PubMed ID: 21163065
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.
Patard JJ; Leray E; Rioux-Leclercq N; Cindolo L; Ficarra V; Zisman A; De La Taille A; Tostain J; Artibani W; Abbou CC; Lobel B; Guillé F; Chopin DK; Mulders PF; Wood CG; Swanson DA; Figlin RA; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2005 Apr; 23(12):2763-71. PubMed ID: 15837991
[TBL] [Abstract][Full Text] [Related]
20. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma.
Furge KA; Chen J; Koeman J; Swiatek P; Dykema K; Lucin K; Kahnoski R; Yang XJ; Teh BT
Cancer Res; 2007 Apr; 67(7):3171-6. PubMed ID: 17409424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]